Learning in Young Adults as Predictor for the Development of Alcohol Use Disorders
NCT ID: NCT01744834
Last Updated: 2022-04-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
201 participants
OBSERVATIONAL
2012-12-31
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The researchers aim is to characterise a representative sample (200 men at age 18) with regard to learning parameters and their respective neural correlates which are thought to be indicators for the risk to develop an alcohol use disorder.
As part of a large multi-center study on alcohol dependency (in Dresden \& Berlin, Germany) the researchers will characterize the sample and then prospectively assess alcohol consumption and development of AUDs over a period of three years plus additional follow-ups after that period, depending on future funding.
Among other hypotheses it is expected that increased activation of striatal and prefrontal brain regions by the Pavlovian-to-instrumental transfer process is related to increased risk of developing an AUD.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Project 4: Acute Effects of Alcohol on Learning and Habitization in Healthy Young Adults
NCT01858818
Risk and Protective Factors of Children and Adolescents Who Were Hospitalized Due to Alcohol Intoxication
NCT01692054
Effect of Cognitive Training on Alcohol Use Outcomes
NCT02113618
Brief Alcohol Intervention in General Hospitals
NCT00423904
Adverse Childhood Experiences in Alcohol Use Disorder
NCT05048758
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The specific aim is to test a set of related hypotheses. The researchers assume that high risk for AUD at baseline (cross-sectional design), increase of alcohol consumption after 3 years and incidence or progression of AUD during follow-up (prospective data) will be associated with decreased reward sensitivity, decreased punishment sensitivity, increased Pavlovian approach behavior ('sign tracking'), increased 'go' effect of conditioned appetitive stimuli, increased habitization, increased activation of striatal and prefrontal brain regions by the Pavlovian-to-instrumental transfer process, decreased correlation between striatal brain activity and prediction error during reversal learning.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
18-year-old males
18-year-old males, representative random sample of the Dresden/Berlin (Germany) area, categorized as high and as low-risk drinkers respectively
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ability to provide fully informed consent and to use self-rating scales
* habitual social drinking during the three months preceding participation, defined by at least two drinking days in any four weeks-interval
* being able to provide information concerning biological parents and grandparents
Exclusion Criteria
* current diagnosis of one of the following disorders: major depressive disorder, generalized anxiety disorder, PTSD, borderline personality disorder, or obsessive-compulsive disorder
* prior treatment for any axis-I or axis-II disorder except for specific disorders of childhood and adolescence (i.e., oppositional defiant disorder, conduct disorder, ADHD)
* history of substance dependence other than nicotine dependence
* current substance use other than nicotine and alcohol as evinced by positive urine screen
* history of severe head trauma or other severe central neurological disorder (e.g. multiple sclerosis)
* any alcohol intake in the last 24 hours before test days
* use of medications or illicit substances known to interact with the central nervous system within the last 10 days or at least four half-lives post last intake
18 Years
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Technische Universität Dresden
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Smolka, Prof MD
Role: PRINCIPAL_INVESTIGATOR
Technische Universität Dresden, Dresden, Germany
Andreas Heinz, Prof MD
Role: PRINCIPAL_INVESTIGATOR
Charité University, Berlin, Germany
Andreas Heinz, Prof MD
Role: STUDY_CHAIR
Charité University, Berlin, Germany
Hans-Ulrich Wittchen, Prof PhD
Role: STUDY_DIRECTOR
Technische Universität Dresden, Dresden, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Technische Universität Dresden
Dresden, Saxony, Germany
Universitaetsklinikum Carl Gustav Carus at the Technische Universitaet Dresden
Dresden, Saxony, Germany
Charité - Universitätsmedizin Berlin
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
English study description
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HE2597/13-1;SM80/71;WI709/10-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.